Fig. 4From: Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trialSymptom relief and quality of life. A Subject-reported overall symptom of allergic rhinitis. Study subjects were asked to score their overall symptom of allergic rhinitis on a VAS. B Total mean score of SNOT-20. C Total mean score of RQLQ. *P < 0.05. VAS visual analog scale, SNOT-20 sinonasal outcome test-20, RQLQ rhinoconjunctivitis quality of life questionnaireBack to article page